These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 31627429)
1. Aspatwar A; Kairys V; Rala S; Parikka M; Bozdag M; Carta F; Supuran CT; Parkkila S Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627429 [TBL] [Abstract][Full Text] [Related]
2. Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on Aspatwar A; Winum JY; Carta F; Supuran CT; Hammaren M; Parikka M; Parkkila S Molecules; 2018 Nov; 23(11):. PubMed ID: 30413024 [TBL] [Abstract][Full Text] [Related]
3. β-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis. Aspatwar A; Hammarén M; Koskinen S; Luukinen B; Barker H; Carta F; Supuran CT; Parikka M; Parkkila S J Enzyme Inhib Med Chem; 2017 Dec; 32(1):832-840. PubMed ID: 28629306 [TBL] [Abstract][Full Text] [Related]
4. The β-carbonic anhydrases from Mycobacterium tuberculosis as drug targets. Nishimori I; Minakuchi T; Maresca A; Carta F; Scozzafava A; Supuran CT Curr Pharm Des; 2010; 16(29):3300-9. PubMed ID: 20819064 [TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. Carta F; Maresca A; Covarrubias AS; Mowbray SL; Jones TA; Supuran CT Bioorg Med Chem Lett; 2009 Dec; 19(23):6649-54. PubMed ID: 19846301 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs. Supuran CT Curr Med Chem; 2012; 19(6):831-44. PubMed ID: 22214451 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the β-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity. Buchieri MV; Riafrecha LE; Rodríguez OM; Vullo D; Morbidoni HR; Supuran CT; Colinas PA Bioorg Med Chem Lett; 2013 Feb; 23(3):740-3. PubMed ID: 23265903 [TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides. Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511 [TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis. Del Prete S; Vullo D; De Luca V; AlOthman Z; Osman SM; Supuran CT; Capasso C J Enzyme Inhib Med Chem; 2015 Jun; 30(3):366-70. PubMed ID: 25032746 [TBL] [Abstract][Full Text] [Related]
12. Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: kinetic and computational investigations. Cau Y; Mori M; Supuran CT; Botta M Org Biomol Chem; 2016 Sep; 14(35):8322-30. PubMed ID: 27530867 [TBL] [Abstract][Full Text] [Related]
13. Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Del Prete S; Vullo D; De Luca V; Carginale V; Ferraroni M; Osman SM; AlOthman Z; Supuran CT; Capasso C Bioorg Med Chem; 2016 Mar; 24(5):1115-20. PubMed ID: 26850377 [TBL] [Abstract][Full Text] [Related]
14. Bacterial, fungal and protozoan carbonic anhydrases as drug targets. Capasso C; Supuran CT Expert Opin Ther Targets; 2015; 19(12):1689-704. PubMed ID: 26235676 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis. Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Innocenti A; Supuran CT J Med Chem; 2009 May; 52(9):3116-20. PubMed ID: 19338333 [TBL] [Abstract][Full Text] [Related]
16. Anti-tubercular and antioxidant activities of C-glycosyl carbonic anhydrase inhibitors: towards the development of novel chemotherapeutic agents against Mycobacterium tuberculosis. Zaro MJ; Bortolotti A; Riafrecha LE; Concellón A; Morbidoni HR; Colinas PA J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1726-30. PubMed ID: 27146440 [TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c β-carbonic anhydrase from Mycobacterium tuberculosis and design of not yet synthesized new molecules. Singh S; Supuran CT J Enzyme Inhib Med Chem; 2014 Jun; 29(3):449-55. PubMed ID: 23808803 [TBL] [Abstract][Full Text] [Related]